Inventor · disambiguated record
Maria R. Parkhurst
Also filed as: PARKHURST MARIA · PARKHURST MARIA R
8 granted patents·5 pending applications·26 citations·filing 2002–2024
81Inventor score
Files withUS HEALTH10HWU PATRICK1THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN1THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC1
Top patents by PatentIndex Score
13 records- 0191US9487573B2Murine anti-NY-ESO-1 T cell receptorsUS HEALTH·Filed 2013·Granted Nov 8, 2016·19 cites·27 claims
- 0278US7749967B2Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methodsUS HEALTH·Filed 2008·Granted Jul 6, 2010·2 cites·15 claims
- 0374US11939365B2T cell receptors recognizing mutated P53US HEALTH·Filed 2018·Granted Mar 26, 2024·1 cites·19 claims
- 0471US2024270814A1T cell receptors recognizing mutated p53THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 0569US7419957B2Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methodsUS HEALTH·Filed 2002·Granted Sep 2, 2008·4 cites·8 claims
- 0662US12448428B2HLA class II-restricted t cell receptors against RAS with G12R mutationUS HEALTH·Filed 2020·Granted Oct 21, 2025·0 cites·37 claims
- 0759US10407485B2Murine anti-NY-ESO-1 T cell receptorsUS HEALTH·Filed 2018·Granted Sep 10, 2019·0 cites·16 claims
- 0859US2009068141A1Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancerUS HEALTH·Filed 2008·Application pending·0 cites
- 0954US10087230B2Murine anti-NY-ESO-1 T cell receptorsUS HEALTH·Filed 2016·Granted Oct 2, 2018·0 cites·11 claims
- 1053US2024254190A1T cell receptors recognizing c135y, r175h, or m237i mutation in p53THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN·Filed 2022·Application pending·0 cites
- 1151US8252545B2Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methodsHWU PATRICK·Filed 2010·Granted Aug 28, 2012·0 cites·20 claims
- 1249US2023257440A1Hla class ii-restricted drb t cell receptors against ras with g12v mutationUS HEALTH·Filed 2021·Application pending·0 cites
- 1348US2023082787A1Hla class i-restricted t cell receptors against ras with g12v mutationUS HEALTH·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maria R. Parkhurst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →